Vasoconstrictor effect and mechanism of action of endothelin-1 in human radial artery and vein: Implication of skin flap vasospasm

Journal of Cardiovascular Pharmacology

Volumn 41, Issue 3, 2003, Pages 460-467

  Black, Claire E ^a,b   Huang, Ning ^b   Neligan, Peter C ^a,b   Forrest, Christopher R ^a,b   Lipa, Joan E ^a,b   Pang, Cho Y ^a,b,c  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

ETA receptors; Intracellular Ca2+; L type Ca2+ channels; Protein kinase C; Radial artery and vein

Indexed keywords

[1,2 BIS (2 AMINOPHENOXY)]ETHANE N,N,N',N' TETRAACETIC ACID TETRAACETOXY METHYL ESTER; BUFFER; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM CHANNEL L TYPE; CALCIUM CHELATING AGENT; CHELERYTHRINE; CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); ENDOTHELIN 1; ENDOTHELIN A RECEPTOR ANTAGONIST; ETHYLENE GLYCOL 1,2 BIS(2 AMINOPHENYL) ETHER N,N,N',N' TETRAACETIC ACID; NIFEDIPINE; PROTEIN KINASE C INHIBITOR; UNCLASSIFIED DRUG;

ARTERY CONSTRICTION; ARTICLE; CALCIUM CELL LEVEL; CONCENTRATION RESPONSE; DRUG POTENCY; FREE TISSUE GRAFT; GANGRENE; HUMAN; HUMAN TISSUE; MUSCLE ISOMETRIC CONTRACTION; PATHOPHYSIOLOGY; PEDICLED SKIN FLAP; PRIORITY JOURNAL; RADIAL ARTERY; RADIAL VEIN; SKIN TRANSPLANTATION; VASOSPASM; VEIN; VENOCONSTRICTION;

ADULT; AGED; ANALYSIS OF VARIANCE; ARM; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIN-1; FEMALE; HUMANS; MALE; MIDDLE AGED; RADIAL ARTERY; STATISTICS, NONPARAMETRIC; SURGICAL FLAPS; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS; VEINS;

EID: 0037369512     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-200303000-00015     Document Type: Article

References (29)

1. Daniel RK, Kerrigan CL. Principles and physiology of skin flap surgery. In: McCarthy DG, ed. Plastic Surgery (General Principles, Volume 1). Philadelphia: WB Saunders, 1990:275-328.
2. Manktelow RT. Microvascular Reconstruction: Anatomy, Applications and Surgical Technique. New York: Springer-Verlag, 1987.
3. Afridi NS, LiPaletz J, Morris SF. Free flap failure: what to do next? Can J Plast Surg. 2000;8:30-2.
4. Serletti JM, Moran SL. Free versus the pedicle tram flap: a cost comparison and outcome analysis. Plast Reconstr Surg. 1997;100:1418-27.
5. Heinz TR, Cowper PA, Levin LS. Microsurgery costs and outcome. Plast Reconstr Surg. 1999;104:89-96.
6. May JW Jr, Chait LA, O'Brien BM, et al. The no reflow phenomenon in experimental free flaps. Plast Reconstr Surg. 1978;61:256-67.
7. Weinzweig N, Gonzalez M. Free tissue failure is not an all-or-none phenomenon. Plast Reconstr Surg. 1995;96:648-60.
8. Kaplan EN, Strachan TR. Flap design: the anatomic and physiological basis. In: Kernahan DA, Vistnes LM, ed. Biological Aspects of Reconstructive Surgery. Boston: Little, Brown, 1977:257-9.
9. Kerrigan CL, Wizman P, Hjortdal VE, et al. Global flap ischemia: a comparison of arterial versus venous etiology. Plast Reconstr Surg. 1994;93:1485-95.
10. 2 and prostacyclin production: modification by thromboxane synthesis inhibitor. Ann Plast Surg. 1988;20:106-11.
11. Angel MF, Knight KR, Mellow CG, et al. The effect of prior elevation of skin flaps and ischemia on blood thromboxane levels. Ann Plast Surg. 1989;22:501-4.
12. Pang CY, Forrest CR, Morris SF. Pharmacologic augmentation of skin flap viability: a hypothesis to mimic the surgical delay phenomenon of skin flap viability. Ann Plast Surg. 1989;22:293-306.
13. He W, Neligan P, Lipa J, et al. Comparison of secondary ischemic tolerance between pedicled and free island buttock skin flaps in the pig. Plast Reconstr Surg. 1997;100:72-81.
14. Matsuzaki K. Effect of skin flap ischemia on plasma endothelin-1 levels. Ann Plast Surg. 1993;31:499-503.
15. 2 in random pattern flaps. J Cardiovasc Pharmacol. 1998;31(suppl 1):S477-9.
16. Miller RC, Pelton JT, Huggins JP. Endothelins: from receptors to medicine. Trends Pharmacol Sci. 1993, 14:54-60.
17. Doherty AM. Endothelium-17 structive and development of receptor antagonists. In: Weiner DB, William B, eds. Chemical and Structural Approaches to Rational Drug Design. Boca Raton, FL: CRC Press, 1995:85-123.
18. Haynes WG, Webb DJ. Endothelin as a regulation of cardiovascular function in health and disease. J Hypertens. 1998;16:1081-98.
19. Lipa JE, Neligan PC, Perreault TM, et al. Vasoconstrictor effect of endothelin-1 in human skin: role of ETA and ETB receptors. Am J Physiol. 1999;276(2 part 2):H359-67.
20. Wenzel RR, Noll G, Lüscher TF. Endothelin receptor antagonist inhibit endothelin in human skin microcirculation. Hypertension. 1994;23:581-6.
21. Liu, JJ, Chen JR, Buxton BF. Unique response of human arteries to endothelin B receptor agonist and antagonist. Clin Sci. 1996;90:91-6.
22. Pang CY, Yang RZ, Neligan P, et al. Vascular effects and mechanism of action of endothelin-1 in isolated perfused pig skin. J Appl Physiol. 1995;79:2106-13.
23. Pang CY, Xu H, Huang N, et al. Amplification effect and mechanism of action of endothelin-1 in U46619-induced vasoconstriction in pig skin. Am J Physiol. 2001;280:R713-20.
24. Fukuroda T, Fujikawa T, Ozaki S, et al. Clearance of circulating endothelin-1 by ETB receptors in rats. Biochem Biophys Res Commun. 1994;199:146-1465.
25. Miller RC, Pelton JT, Huggins JP. Endothelins from receptors to medicine. Trends Pharmacol Sci. 1993;14:54-60.
26. Doherty AM. Endothelin structure and development of receptor antagonists In: Weiner DB, William B, eds. Chemical and Structural Approaches to Rational Drug Design. Boca Raton, FL: CRC Press, 1995:85-123.
27. Haynes WG, Webb DJ. Endothelin as a regulation of cardiovascular function in health and disease. J Hypertens. 1998;16:1081-98.
28. Miyauchi T. Pathophysiology of endothelin in the cardiovascular system. Annu Rev Physiol. 1999;61:391-415.
29. Miyauchi T, Tomobe Y, Shiba R, et al. Involvement of endothelin in the regulation of human vascular tonus: potent vasoconstrictor effect and existence in endothelial cells. Circulation. 1990;81:1874-80.